194
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Intra-individual variation of miRNA expression levels in human plasma samples

, , , , , , & show all
Pages 339-346 | Received 03 Aug 2017, Accepted 06 Jan 2018, Published online: 30 Jan 2018

References

  • Ameling, S., et al., 2015. Associations of circulating plasma microRNAs with age, body mass index and sex in a population-based study. BMC medical genomics, 8, 61.
  • Arroyo, J.D., et al., 2011. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proceedings of the national academy of sciences of the United States of America, 108 (12), 5003–5008.
  • Assmann T.S., et al, 2017. MicroRNA expression profiles and type 1 diabetes mellitus: systematic review and bioinformatics analysis. Endocrine connections
  • Bartel, D.P., 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116 (2), 281–297.
  • Bertoia, M.L., et al., 2015. Reproducibility of circulating MicroRNAs in stored plasma samples. PLoS one, 10 (8), e0136665.
  • Carlsen, A.L., et al., 2013. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis and rheumatism, 65 (5), 1324–1334.
  • Castro-Villegas, C., et al., 2015. Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFalpha. Arthritis research & therapy, 17, 49.
  • Chen, X., et al., 2008. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell research, 18 (10), 997–1006.
  • Chim, S.S., et al., 2008. Detection and characterization of placental microRNAs in maternal plasma. Clinical chemistry, 54 (3), 482–490.
  • Creemers, E.E., Tijsen, A.J., and Pinto, Y.M., 2012. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circulation research, 110 (3), 483–495.
  • Denli, A.M., et al., 2004. Processing of primary microRNAs by the microprocessor complex. Nature, 432 (7014), 231–235.
  • Fichtlscherer, S., et al., 2010. Circulating microRNAs in patients with coronary artery disease. Circulation research, 107 (5), 677–684.
  • Fortunato, O., et al., 2014. Assessment of circulating microRNAs in plasma of lung cancer patients. Molecules (Basel, Switzerland), 19 (3), 3038–3054.
  • Geiss, G.K., et al., 2008. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nature biotechnology, 26 (3), 317–325.
  • Hunter, M.P., et al., 2008. Detection of microRNA expression in human peripheral blood microvesicles. PLoS one, 3 (11), e3694.
  • Jarry, J., et al., 2014. The validity of circulating microRNAs in oncology: five years of challenges and contradictions. Molecular oncology, 8 (4), 819–829.
  • Karolina, D.S., et al., 2012. Circulating miRNA profiles in patients with metabolic syndrome. The journal of clinical endocrinology and metabolism, 97 (12), E2271–E2276.
  • Krol, J., Loedige, I., and Filipowicz, W., 2010. The widespread regulation of microRNA biogenesis, function and decay. Nature reviews genetics, 11 (9), 597–610.
  • Kumar, P., et al., 2013. Circulating miRNA biomarkers for Alzheimer's disease. PLoS one, 8 (7), e69807.
  • Lawrie, C.H., et al., 2008. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. British journal of haematology, 141 (5), 672–675.
  • Li, S., et al., 2011. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation, 124 (2), 175–184.
  • Merkerova, M., Belickova, M., and Bruchova, H., 2008. Differential expression of microRNAs in hematopoietic cell lineages. European journal of haematology, 81 (4), 304–310.
  • Merritt, W.M., et al., 2008. Dicer, Drosha, and outcomes in patients with ovarian cancer. The new England journal of medicine, 359 (25), 2641–2650.
  • Mestdagh, P., et al., 2014. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nature methods, 11 (8), 809–815.
  • Mitchell, P.S., et al., 2008. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the national academy of sciences of the United States of America, 105 (30), 10513–10518.
  • Mujahid, S., et al., 2013. miRNA regulated pathways in late stage murine lung development. BMC developmental biology, 13, 13.
  • Musumeci, M., et al., 2011. Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Oncogene, 30 (41), 4231–4242.
  • Peters, T.M., et al., 2010. Accelerometer-measured physical activity in Chinese adults. American journal of preventive medicine, 38 (6), 583–591.
  • Reid, G., Kirschner, M.B., and van, Z.N., 2011. Circulating microRNAs: association with disease and potential use as biomarkers. Critical reviews in oncology/hematology, 80 (2), 193–208.
  • Sharma, S., and Eghbali, M., 2014. Influence of sex differences on microRNA gene regulation in disease. Biology of sex differences, 5 (1), 3
  • Shin, V.Y., et al., 2015. Circulating cell-free miRNAs as biomarker for triple-negative breast cancer. British journal of cancer, 112 (11), 1751–1759.
  • Shu, X.O., et al., 2015. Cohort profile: The Shanghai men's health study. International journal of epidemiology, 44 (3), 810–818.
  • Siegel, C., et al., 2011. miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proceedings of the national academy of sciences of the United States of America , 108 (28), 11662–11667.
  • Soreq, L., et al., 2013. Overlapping molecular signatures in Parkinson's patients' leukocytes before and after treatment and in mouse model brain regions. CNS & neurological disorders – drug targets, 12 (8), 1086–1093.
  • Tanaka, M., et al., 2009. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS one, 4 (5), e5532
  • Tijsen, A.J., et al., 2010. MiR423-5p as a circulating biomarker for heart failure. Circulation research , 106 (6), 1035–1039.
  • Tijsen, A.J., Pinto, Y.M., and Creemers, E.E., 2012. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. American journal of physiology-heart and circulatory physiology, 303 (9), H1085–H1095.
  • Valadi, H., et al., 2007. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature cell biology , 9 (6), 654–659.
  • Vegter, E.L., et al., 2016. Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure. International journal of cardiology, 224, 231–239.
  • Vickers, K.C., et al., 2011. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nature cell biology, 13 (4), 423–433.
  • Wang, G.K., et al., 2010. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. European heart journal, 31 (6), 659–666.
  • Wang, K., et al., 2010. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic acids research, 38 (20), 7248–7259.
  • Wang, R., et al., 2011. Circulating microRNAs are promising novel biomarkers of acute myocardial infarction. Internal medicine, 50 (17), 1789–1795.
  • Wang, Y.T., et al., 2013. Circulating microRNAs have a sex-specific association with metabolic syndrome. Journal of biomedical science, 20, 72.
  • Wu, X., et al., 2010. Intra-person variation of urinary biomarkers of oxidative stress and inflammation. Cancer epidemiology biomarkers & prevention, 19 (4), 947–952.
  • Zampetaki, A., et al., 2010. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circulation research, 107 (6), 810–817.
  • Zernecke, A., et al., 2009. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Science signaling, 2 (100), ra81.
  • Zheng, W., et al., 2005. The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. American journal of epidemiology, 162 (11), 1123–1131.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.